{
  "docId": "019dd923-622b-71dc-a6db-8db9eda08bf8",
  "docSlug": "80938ee8f28c",
  "documentTitle": "E.I. du Pont de Nemours and Company (DuPont) (DD)",
  "authorId": "06_Trian_Partners",
  "authorName": "Nelson Peltz",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-04-22 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2631578,
  "pageNumber": 27,
  "pageCount": 88,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 24,
  "notes": "Uses a combination of bar charts and a table to demonstrate value destruction.",
  "elementsJson": [
    "headline_text",
    "bar_chart_vertical",
    "data_table",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6db-8db9eda08bf8/27",
  "deckHref": "/decks/019dd923-622b-71dc-a6db-8db9eda08bf8",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6db-8db9eda08bf8.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6db-8db9eda08bf8#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.74,
        "x": 0.13,
        "y": 0.72
      },
      "kind": "callout",
      "text": "DuPont's inability to generate an attractive return in its non-Agriculture businesses (68% of revenues) is concerning especially in light of the current headwinds in Agriculture markets",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7931994-9c3b-4448-af68-dbb03a37055e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.36,
        "x": 0.13,
        "y": 0.21
      },
      "kind": "chart",
      "text": "Sales ex Agriculture and Pharma (2007-2014)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a75159a-c49c-4007-a7e3-1cc3801d14c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.36,
        "x": 0.13,
        "y": 0.46
      },
      "kind": "chart",
      "text": "Pre-R&D EBITDA ex Agriculture and Pharma (2007-2014)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1709784c-f159-459d-8436-31df36b57c3d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.36,
        "x": 0.51,
        "y": 0.46
      },
      "kind": "chart",
      "text": "Uneconomic ROIC(1): Significantly Below WACC(2)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "449ac88d-3eed-477f-b85e-12038e317cec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "ROIC: 5.0%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-14d8-75c0-8c7e-ee62d78b2da8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.74,
        "x": 0.13,
        "y": 0.8
      },
      "kind": "source-note",
      "text": "Source: Company SEC filings, Trian Estimates and Company Data Books.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad1e460a-f967-4506-861a-f7a60acf65f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.36,
        "x": 0.51,
        "y": 0.21
      },
      "kind": "table",
      "text": "Capital Expenditures, Net Acquisitions & Research and Development",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01f5c5aa-e27d-4c53-8284-ed98cc8e5857",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.74,
        "x": 0.13,
        "y": 0.16
      },
      "kind": "title",
      "text": "Uneconomic ROIC On 2/3rds Of The Revenue Base (Ex Ag & Pharma)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9c2a261-3c45-4127-bf62-cd24100f9894",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "capital-allocation-framework",
      "slug": null,
      "matchId": "e2a84a9d-ecf8-402e-a50c-37056cb6f951",
      "evidence": "Analysis of ROIC vs WACC and capital expenditure efficiency",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 21,
      "beatId": "4902bd43-8f6a-432e-9a98-ff330420aa55",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "Root cause of DuPont's underperformance",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 30,
      "from": 21,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "05802e52-57d3-4841-85fb-eb2c5315a7a4",
      "evidence": "Excess corporate costs and poor governance",
      "position": 1,
      "objective": "Highlight the cost of inaction",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}